Covered Tests

MolDX reviews test registration applications and technical assessments (TA) to confirm that each test meets Medicare reasonable and necessary criteria. Covered tests reviewed through the TA process are identified in the Molecular Diagnostic Test policy found in the LCD section. Coding and Billing guidelines are available to facilitate reimbursement.

MolDX Covered Tests

Article Title
Article ID#
Afirma Assay by Veracyte Coding and Billing Guidelines (M00015)
AlloMap Coding and Billing Guidelines (M00016)
Avise PG Assay Billing/Coding Update (M00026)
BCR-ABL Coding and Billing Guidelines (M00044)
Billing and Coding for Lynch Syndrome Testing Services (M00131)
bioTheranostics Cancer TYPE ID Update (M00027)
Bladder Tumor Marker FISH Coding and Coding Guidelines (M00001)
Coding and Billing for Abbott RealTime IDH2 testing for Acute Myeloid Leukemia (AML) (M00145)
Controlled Substance Monitoring and Drugs of Abuse Coding and Billing Guidelines (M00128)
CYP2C9 and/or VKORC1 Gene Testing for Warfarin Response Coding and Billing Guidelines (M00040)
FDA Approved CLL Companion Diagnostic Test Coding and Billing Guidelines (M00153)
FDA-Approved BRAF Tests (M00111)
FDA-Approved EGFR Tests (M00110)
FDA-Approved KRAS Tests (M00121)
HERmark Assay by Monogram Coding and Billing Guidelines (M00028)
Immunohistochemistry (IHC) Indications for Breast Pathology (M00094)
MammaPrint Billing and Coding Guidelines Update (M00029)
Microsatellite Instability-High (MSI-H) and Mismatch Repair Deficient (dMMR) Biomarker Coding and Billing Guidelines for Patients with Unresectable or Metastatic Solid Tumors (M00142)
Myriad's BRACAnalysis CDx Coding and Billing Guidelines (M00120)
Next Generation Sequencing Coding and Billing Guidelines (M00127)
Oncotype DX Breast Cancer Assay Coding and Billing Guidelines (M00003)
Oncotype DX Colon Cancer Assay Coding and Billing Guidelines (M0002)
Progensa PCA3 Assay Coding and Billing Guidelines (M00013)
ResponseDX Tissue of Origin Coding and Billing Guidelines (M00034)
Short Tandem Repeat (STR) Markers and Chimerism Coding and Billing Guidelines (M00129)
ThermoFisher Oncomine Dx Target Test For Non-Small Cell Lung Cancer, Coding and Billing Guidelines (M00150)
Vectra DA Coding and Billing Guidelines (M00031)